title: Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia.
authors.affiliation: Department of Clinical Haematology, The Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
authors.forename: K D
authors.initials: KD
authors.lastname: Cummins
authors.affiliation: Department of Clinical Haematology, The Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
authors.forename: S M
authors.initials: SM
authors.lastname: Jane
authors.forename: S
authors.initials: S
authors.lastname: Ninkovic
authors.affiliation: Department of Haematology, St Vincent's Hospital, East Melbourne, Victoria, Australia.
authors.forename: S
authors.initials: S
authors.lastname: Nikovic
authors.affiliation: Department of Haematology, St Vincent's Hospital, East Melbourne, Victoria, Australia.
authors.forename: A
authors.initials: A
authors.lastname: Bazargan
authors.affiliation: Department of Haematology, St Vincent's Hospital, East Melbourne, Victoria, Australia.
authors.forename: R
authors.initials: R
authors.lastname: Filshie
authors.affiliation: Department of Haematology, Westmead Hospital, Westmead, New South Wales, Australia.
authors.forename: G
authors.initials: G
authors.lastname: Sutrave
authors.affiliation: Department of Haematology, Westmead Hospital, Westmead, New South Wales, Australia.
authors.forename: M
authors.initials: M
authors.lastname: Hertzberg
authors.affiliation: Department of Haematology, Royal Brisbane Hospital, Herston, Queensland, Australia.
authors.forename: A
authors.initials: A
authors.lastname: Scott
authors.affiliation: Department of Haematology, Royal Brisbane Hospital, Herston, Queensland, Australia.
authors.forename: S
authors.initials: S
authors.lastname: Lane
authors.affiliation: Department of Haematology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
authors.forename: C K
authors.initials: CK
authors.lastname: Yannakou
authors.affiliation: Department of Haematology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
authors.forename: D
authors.initials: D
authors.lastname: Ritchie
authors.affiliation: Department of Haematology, Canberra Hospital, Garran, Australian Capital Territory, Australia.
authors.forename: J
authors.initials: J
authors.lastname: D'Rozario
authors.affiliation: Department of Haematology, Cairns and Hinterland Hospital and Health Service, Cairns, Queensland, Australia.
authors.forename: J
authors.initials: J
authors.lastname: Black
authors.affiliation: Department of Haematology, Cairns and Hinterland Hospital and Health Service, Cairns, Queensland, Australia.
authors.forename: K
authors.initials: K
authors.lastname: Bavishi
authors.affiliation: Department of Clinical Haematology, The Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
authors.forename: A
authors.initials: A
authors.lastname: Wei
mesh_terms: D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009536:Niacinamide / Q000008:administration & dosage / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000008:administration & dosage*; D016879:Salvage Therapy; D000077157:Sorafenib; D051941:fms-Like Tyrosine Kinase 3 / Q000037:antagonists & inhibitors / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib; C497970:FLT3 protein, human; D051941:fms-Like Tyrosine Kinase 3
references.citation: Blood. 2004 Aug 15;104(4):1145-50
references.pmid: 15126317
references.citation: Leukemia. 2010 Aug;24(8):1437-44
references.pmid: 20535150
references.citation: Leuk Lymphoma. 2013 Feb;54(2):336-41
references.pmid: 22812445
references.citation: Blood. 2011 Mar 24;117(12):3294-301
references.pmid: 21270442
references.citation: Blood. 2012 Nov 8;120(19):4049-57
references.pmid: 22990016